{"id":"https://openalex.org/W4396591271","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po2-04-14","title":"Abstract PO2-04-14: Dual Inhibition of WEE1 and PKMYT1 Synergistically Overcomes CDK4/6 Inhibitor Resistance in Breast Cancer","display_name":"Abstract PO2-04-14: Dual Inhibition of WEE1 and PKMYT1 Synergistically Overcomes CDK4/6 Inhibitor Resistance in Breast Cancer","publication_year":2024,"publication_date":"2024-05-02","ids":{"openalex":"https://openalex.org/W4396591271","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po2-04-14"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs23-po2-04-14","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po2-04-14","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs23-po2-04-14","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089455074","display_name":"Mei\u2010Kuang Chen","orcid":"https://orcid.org/0000-0001-8027-8990","observed_orcids":["https://orcid.org/0000-0001-8027-8990"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mei-Kuang Chen","raw_affiliation_strings":["1Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5096043063","display_name":"Grace DeAlessandro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grace DeAlessandro","raw_affiliation_strings":["1Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000113218","display_name":"Tuyen N. Bui","orcid":"https://orcid.org/0000-0001-8509-3653","observed_orcids":["https://orcid.org/0000-0001-8509-3653"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tuyen Bui","raw_affiliation_strings":["2The University of Texas MD Anderson Cancer Center, Houston, Texas, United States;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The University of Texas MD Anderson Cancer Center, Houston, Texas, United States;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042960706","display_name":"Khandan Keyomarsi","orcid":"https://orcid.org/0000-0002-5440-0849","observed_orcids":["https://orcid.org/0000-0002-5440-0849"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khandan Keyomarsi","raw_affiliation_strings":["3Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"9_Supplement","first_page":"PO2","last_page":"04"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/wee1-inhibition","display_name":"WEE1 inhibition","score":0.8920000195503235},{"id":"https://openalex.org/keywords/palbociclib-resistance","display_name":"palbociclib resistance","score":0.8399999737739563},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8650000095367432},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/replication-stress","display_name":"replication stress","score":0.8859999775886536},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.8190000057220459},{"id":"https://openalex.org/keywords/rad51","display_name":"RAD51","score":0.7649999856948853},{"id":"https://openalex.org/keywords/g2-m-cell-cycle-arrest","display_name":"G2/M cell cycle arrest","score":0.843999981880188},{"id":"https://openalex.org/keywords/mk-1775","display_name":"MK-1775","score":0.718999981880188},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7699999809265137},{"id":"https://openalex.org/keywords/organoids","display_name":"organoids","score":0.6629999876022339},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.5120000243186951}],"concepts":[{"id":"https://openalex.org/C2781252693","wikidata":"https://www.wikidata.org/wiki/Q7979264","display_name":"Wee1","level":5,"score":0.6225543022155762},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5952308773994446},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5023031234741211},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5002691745758057},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.422200083732605},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3642873466014862},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35207733511924744},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32469695806503296},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.05127072334289551},{"id":"https://openalex.org/C120504264","wikidata":"https://www.wikidata.org/wiki/Q1147372","display_name":"Cyclin-dependent kinase 1","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs23-po2-04-14","doi":"https://doi.org/10.1158/1538-7445.sabcs23-po2-04-14","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs23-po2-04-14","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409624914","https://openalex.org/W4413103906","https://openalex.org/W4409690539","https://openalex.org/W2972772689","https://openalex.org/W7083287160","https://openalex.org/W7155164992","https://openalex.org/W4409246283","https://openalex.org/W4410282465","https://openalex.org/W4398256251","https://openalex.org/W4362595947"],"abstract_inverted_index":{"Abstract":[0],"Cyclin-dependent":[1],"kinase":[2],"4/6":[3],"inhibitors":[4,31,212,252,325],"(CDK4/6i)":[5],"are":[6,183],"approved":[7],"for":[8,151,209,326,414],"the":[9,25,40,115,207,222,284,288,291,301,370,386,421,456],"treatment":[10,88,249],"of":[11,27,51,137,225,236,268,278,290,304,318,336,390,393,424,440,455],"advanced":[12],"estrogen":[13],"receptor-positive,":[14],"HER2-negative":[15],"(ER+ve)":[16],"breast":[17,57,64,68,95,240,315,406],"cancer":[18,58,69,96,241,316,407],"when":[19],"combined":[20],"with":[21,213,243,250],"endocrine":[22,365],"therapy.":[23,427],"However,":[24],"emergence":[26],"resistance":[28,45,202,246,401],"to":[29,106,113,203,254,379],"CDK4/6":[30,43,61,92,324,348,399,446],"poses":[32],"a":[33,48,169,194,234,412],"significant":[34],"clinical":[35,198,302,416,422],"challenge.":[36],"This":[37],"study":[38,384],"investigates":[39],"mechanisms":[41],"underlying":[42],"inhibitor":[44,227,231,400],"and":[46,60,91,139,149,155,166,229,238,307,338,364,395,404,442],"identifies":[47],"common":[49,170],"occurrence":[50],"high":[52],"replication":[53,108],"stress":[54],"in":[55,119,144,172,233,296,346,397,402,449],"triple-negative":[56],"(TNBC)":[59],"inhibitor-resistant":[62,93,349],"ER+ve":[63,67,94,239,405],"cancers.":[65],"While":[66],"patients":[70,319,358],"have":[71,200],"benefited":[72],"from":[73,313,357],"targeted":[74],"therapy,":[75],"TNBC":[76,90,237,403],"patients,":[77],"particularly":[78],"those":[79],"without":[80],"germline":[81],"BRCA1/2":[82],"or":[83],"PALB2":[84],"mutations,":[85],"lack":[86],"effective":[87,342],"options.":[89],"cells":[97,242],"exhibit":[98],"an":[99],"increased":[100,262],"dependence":[101],"on":[102,129,323,362],"cell":[103,116,146,152,175],"cycle":[104,117,147,153,176],"arrest":[105,154],"repair":[107,293],"stress-induced":[109],"DNA":[110,121,156,257,279,292],"damage.":[111,280],"Failure":[112],"exit":[114],"results":[118,331],"excessive":[120,255],"damage,":[122,258],"thereby":[123],"limiting":[124],"their":[125,181],"proliferative":[126],"potential.":[127],"Based":[128],"these":[130],"findings,":[131],"we":[132,282,310,367],"hypothesize":[133],"that":[134,188,333,369],"dual":[135,305,334,391],"inhibition":[136,335,392],"WEE1":[138,165,211,226,306,337,394,441],"PKMYT1,":[140],"two":[141],"kinases":[142,191],"involved":[143],"G2/M":[145,174],"transition":[148,177],"crucial":[150],"damage":[157],"repair,":[158],"could":[159],"synergistically":[160],"inhibit":[161],"tumor":[162,375],"growth.":[163],"Although":[164],"PKMYT1":[167,218,230,308,339,396,443],"share":[168],"function":[171],"promoting":[173],"through":[178],"CDK1":[179],"phosphorylation,":[180],"functions":[182],"not":[184],"entirely":[185],"redundant,":[186],"suggesting":[187],"targeting":[189],"both":[190,251],"may":[192],"elicit":[193],"synergistic":[195,223],"response.":[196],"Recent":[197],"trials":[199,417],"shown":[201],"WEE1-targeted":[204],"monotherapies,":[205],"emphasizing":[206],"need":[208],"combining":[210],"other":[214],"agents,":[215],"such":[216],"as":[217,259],"inhibitors.":[219],"We":[220],"demonstrate":[221,332],"effects":[224,377],"(MK1775/AZD1775)":[228],"(RP6306)":[232],"panel":[235],"acquired":[244],"palbociclib":[245,363],"(PalboR).":[247],"Combination":[248],"leads":[253],"unrepaired":[256],"indicated":[260],"by":[261],"\u03b3H2AX":[263],"foci":[264],"following":[265],"48":[266],"hours":[267],"combination":[269,286,372,426],"treatment,":[270,366],"whereas":[271],"single-agent":[272,344],"treatments":[273,345],"induce":[274],"significantly":[275],"lower":[276],"levels":[277],"Furthermore,":[281],"observed":[283],"AZD1775/RP6306":[285,371],"decreases":[287],"expression":[289],"protein":[294],"Rad51":[295],"PalboR":[297],"cells.":[298],"To":[299],"evaluate":[300],"potential":[303,387],"inhibition,":[309],"generated":[311],"organoids":[312],"metastatic":[314],"lesions":[317],"who":[320,359],"had":[321,360],"progressed":[322,361],"ex":[327],"vivo":[328],"studies.":[329],"Our":[330],"is":[340],"more":[341],"than":[343],"eliminating":[347],"organoids.":[350],"Additionally,":[351],"using":[352],"patient-derived":[353],"xenograft":[354],"mouse":[355],"models":[356],"show":[368],"exhibits":[373],"superior":[374],"suppression":[376],"compared":[378],"single":[380],"agents.":[381],"Overall,":[382],"this":[383,425],"highlights":[385],"therapeutic":[388],"benefits":[389],"overcoming":[398],"patients.":[408],"These":[409],"findings":[410],"provide":[411],"rationale":[413],"future":[415],"aimed":[418],"at":[419],"exploring":[420],"utility":[423],"Citation":[428],"Format:":[429],"Mei-Kuang":[430],"Chen,":[431],"Grace":[432],"DeAlessandro,":[433],"Tuyen":[434],"Bui,":[435],"Khandan":[436],"Keyomarsi.":[437],"Dual":[438],"Inhibition":[439],"Synergistically":[444],"Overcomes":[445],"Inhibitor":[447],"Resistance":[448],"Breast":[450,460],"Cancer":[451,461,472],"[abstract].":[452],"In:":[453],"Proceedings":[454],"2023":[457,463],"San":[458,466],"Antonio":[459],"Symposium;":[462],"Dec":[464],"5-9;":[465],"Antonio,":[467],"TX.":[468],"Philadelphia":[469],"(PA):":[470],"AACR;":[471],"Res":[473],"2024;84(9":[474],"Suppl):Abstract":[475],"nr":[476],"PO2-04-14.":[477]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-05-03T00:00:00"}